Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 31 Triple Negative Breast Neoplasms 19 Neoplasm Metastasis 5 Urinary Bladder Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Non-Small-Cell Lung 4 Brain Neoplasms 4 Salivary Gland Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Advanced Breast Cancer 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Bladder Carcinoma 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm, Residual 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Mouth Neoplasms 1 Meningeal Carcinomatosis 1 Lung Diseases 1 Localized Muscle Invasive Bladder Urothelial Carcinoma 1

Interventions

Iodine-131 14 trametinib 9 dabrafenib 9 Thyroidectomy 9 Surgical Procedures, Operative 9 lenvatinib 8 Thyroxine 8 Magnetic Resonance Spectroscopy 8 pembrolizumab 7 Paclitaxel 7 anlotinib 6 Thyrotropin Alfa 6 selpercatinib 5 Sorafenib 5 Saline Solution 5 Radiofrequency Ablation 5 Everolimus 5 pazopanib 4 Vemurafenib 4 Sunitinib 4 Radiotherapy 4 Nivolumab 4 Fluorodeoxyglucose F18 4 Dexmedetomidine 4 Cyclophosphamide 4 Biopsy, Fine-Needle 4 Biopsy 4 Bevacizumab 4 apatinib 3 Triiodothyronine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thyroid Neoplasms × sacituzumab govitecan × Clear all

NCT06923826 2025-07-25

TROP2

National University Hospital, Singapore

Phase 2 Recruiting

Salivary Gland Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡